Int. J. Mol. Sci. 2012, 13(6), 6995-7014; doi:10.3390/ijms13066995
Review

Neuroglobin, a Novel Target for Endogenous Neuroprotection against Stroke and Neurodegenerative Disorders

Zhanyang Yu 1,* email, Ning Liu 1 email, Jianxiang Liu 2 email, Kevin Yang 1 email and Xiaoying Wang 1,* email
1 Neuroprotection Research Laboratory, Department of Neurology and Radiology, Massachusetts General Hospital, Neuroscience Program, Harvard Medical School, Room 2401/2411A, 149 13th Street, Charlestown Boston, MA 02129, USA 2 National Institute for Radiological Protection, China Center for Disease Control and Prevention, Beijing 100088, China
* Authors to whom correspondence should be addressed.
Received: 28 April 2012; in revised form: 25 May 2012 / Accepted: 31 May 2012 / Published: 7 June 2012
(This article belongs to the Special Issue Neuroprotective Strategies 2012)
PDF Full-text Download PDF Full-Text [248 KB, uploaded 7 June 2012 16:27 CEST]
Abstract: Brain neurons and tissues respond to sublethal injury by activating endogenous protective pathways. Recently, following the failure of a large number of clinical trials for protective strategies against stroke that aim to inhibit a specific ischemia response pathway, endogenous neuroprotection has emerged as a more promising and hopeful strategy for development of therapeutics against stroke and neurodegenerative disorders. Neuroglobin (Ngb) is an oxygen-binding globin protein that is highly and specifically expressed in brain neurons. Accumulating evidence have clearly demonstrated that Ngb is an endogenous neuroprotective molecule against hypoxic/ischemic and oxidative stress-related insults in cultured neurons and animals, as well as neurodegenerative disorders such as Alzheimer’s disease, thus any pharmacological strategy that can up-regulate endogenous Ngb expression may lead to novel therapeutics against these brain disorders. In this review, we summarize recent studies about the biological function, regulation of gene expression, and neuroprotective mechanisms of Ngb. Furthermore, strategies for identification of chemical compounds that can up-regulate endogenous Ngb expression for neuroprotection against stroke and neurodegenerative disorders are discussed.
Keywords: neuroglobin; neuroprotection; stroke; neurodegenerative diseases; hypoxia/ischemia; high-throughput screening

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Yu, Z.; Liu, N.; Liu, J.; Yang, K.; Wang, X. Neuroglobin, a Novel Target for Endogenous Neuroprotection against Stroke and Neurodegenerative Disorders. Int. J. Mol. Sci. 2012, 13, 6995-7014.

AMA Style

Yu Z, Liu N, Liu J, Yang K, Wang X. Neuroglobin, a Novel Target for Endogenous Neuroprotection against Stroke and Neurodegenerative Disorders. International Journal of Molecular Sciences. 2012; 13(6):6995-7014.

Chicago/Turabian Style

Yu, Zhanyang; Liu, Ning; Liu, Jianxiang; Yang, Kevin; Wang, Xiaoying. 2012. "Neuroglobin, a Novel Target for Endogenous Neuroprotection against Stroke and Neurodegenerative Disorders." Int. J. Mol. Sci. 13, no. 6: 6995-7014.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert